Women and a child walk by a billboard calling on people to get vaccinated against Covid-19 outside a shopping mall in Beijing, capital of China, on May 24, 2021. - AP
BEIJING (China Daily/ANN): Sinopharm's Covid-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.
The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the Covid-19 pandemic.
